United States was the largest of Dexcom Inc’s 2 reported lines in fiscal 2025, at $3.20B — 81% of $3.96B.
| Contract with Customer, Sales Channel | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $2.14B | $2.59B | $2.82B | $3.20B | ||||||||
| International | $767.80M | $508.40M | $605.70M | $763.30M | ||||||||
| Outside Of The United States | — | — | — | — | ||||||||
| Total | $2.91B | $3.10B | $3.43B | $3.96B |
In fiscal 2025, which ended December 31, 2025, the 2 revenue lines Dexcom Inc reported in this breakdown added up to $3.96B. That was up 15.4% from $3.43B in fiscal 2024. United States was the largest revenue line, at $3.20B or 80.7% of the total, followed by International ($763.30M, 19.3%).
Compared with fiscal 2024, International grew the fastest, rising 26.0% to $763.30M. Over fiscal 2022 to 2025, revenue across these revenue lines went from $2.91B to $3.96B, a compound annual growth rate of 10.8%. United States' share of the total rose from 73.6% to 80.7% over the same years.
The table also keeps 1 revenue line that Dexcom Inc no longer reports, so earlier years can still be read on their original basis; use "Show 1 discontinued" beneath the table to see them. This breakdown covers every fiscal year from 2014 to 2025, as reported in Dexcom Inc's annual filings.
Distributor was the largest of Dexcom Inc’s 2 reported lines in fiscal 2025, at $3.20B — 85% of $3.76B.
| Contract With Customer Sales Channel | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Distributor | $2.47B | $2.59B | $2.82B | $3.20B | ||||||
| Direct | $439.00M | $488.60M | $602.90M | $563.80M | ||||||
| Total | $2.91B | $3.08B | $3.43B | $3.76B |
In fiscal 2025, which ended December 31, 2025, the 2 revenue lines Dexcom Inc reported in this breakdown added up to $3.76B. That is less than the $3.96B in its breakdown by revenue line, so these revenue lines do not account for all of its revenue that year. Distributor was the largest revenue line, at $3.20B or 85.0% of the total, followed by Direct ($563.80M, 15.0%).
Compared with fiscal 2024, Distributor grew the fastest, rising 13.1% to $3.20B. Direct fell the most, down 6.5% to $563.80M.
This breakdown covers every fiscal year from 2016 to 2025, as reported in Dexcom Inc's annual filings.
Dexcom Inc (DXCM) breaks its revenue down by revenue line. In fiscal 2025, its largest revenue line was United States, with $3.20B or 80.7% of the total, followed by International at $763.30M (19.3%).
United States was Dexcom Inc's largest revenue line in fiscal 2025, with $3.20B in revenue, 80.7% of the $3.96B reported across its 2 revenue lines.
Of the Dexcom Inc revenue lines reported in both fiscal 2024 and fiscal 2025, and making up at least 2% of the total, International grew the fastest, rising 26.0% from $605.70M to $763.30M.
Every figure is taken from Dexcom Inc's annual financial filings and shown as reported: each line keeps the name the company gives it, years follow its own fiscal calendar, and lines it has stopped reporting stay in the table for the years they were reported.
The breakdown by revenue line covers fiscal 2014 to 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.